Ophthalmic and Nasal Medication Supply for Indian Army

Work Description - NA

This tender, issued by the Department of Military Affairs under the Ministry of Defence, through the Indian Army's designated procurement platform (GEM/2026/B/7927339), seeks the supply of a diverse range of ophthalmic and nasal medications. The bid window opens on August 31, 2026, at 7:16 PM and closes on September 14, 2026, at 8:00 PM. The requirement encompasses a total quantity of 16,900 units across several critical pharmaceutical categories. Specifically, the tender specifies the procurement of various eye drops including Brimonidine Tartrate 0.2% (5ml), Brimonidine Tartrate 0.2% plus Timolol 0.5% (5ml), Clotrimazole 1% plus Lignocaine 2% (10ml), Brinzolamide plus Brimonidine (5ml), Brinzolamide 1.0% plus Timolol 0.5% (5ml), Bromfenac 0.09% (5ml), Cyclosporine 0.05% (5ml), Dorzolamide 2% (3ml), Flurbiprofen Sodium Ophthalmic Solution 0.03% (5ml), Nepafenac 0.1% (5ml), Prednisolone 1% (quantity not specified but listed), Brinzolamide 10 mg/ml (5ml), Gatifloxacin 0.3% (5ml), Latanoprost 0.005% (2.5ml), and Sulphacetamide 20%. Additionally, the tender includes a requirement for Nasal Spray Mometasone 50 mcg per dose. Interested and qualified suppliers are invited to submit their bids within the stipulated timeframe.